|
Feng, Jinong; Drost, Joni B; Scaringe, William A et al. (2002) Mutations in the factor IX gene (F9) during the past 150 years have relative rates similar to ancient mutations. Hum Mutat 19:49-57
|
|
Hill, Kathleen A; Sommer, Steve S (2002) p53 as a mutagen test in breast cancer. Environ Mol Mutagen 39:216-27
|
|
Sommer, S S; Scaringe, W A; Hill, K A (2001) Human germline mutation in the factor IX gene. Mutat Res 487:1-17
|
|
Li, X; Scaringe, W A; Hill, K A et al. (2001) Frequency of recent retrotransposition events in the human factor IX gene. Hum Mutat 17:511-9
|
|
Li, X; Drost, J B; Roberts, S et al. (2000) Factor IX mutations in South Africans and African Americans are compatible with primarily endogenous influences upon recent germline mutations. Hum Mutat 16:371
|
|
Liu, J Z; Li, X; Drost, J et al. (2000) The human factor IX gene as germline mutagen test: samples from Mainland China have the putatively endogenous pattern of mutation. Hum Mutat 16:31-6
|
|
Drost, J B; Scaringe, W A; Jaloma-Cruz, A R et al. (2000) Novel hotspot detector software reveals a non-CpG hotspot of germline mutation in the factor IX gene (F9) in Latin Americans. Hum Mutat 16:203-10
|
|
Feng, J; Buzin, C H; Tang, S H et al. (1999) Highly sensitive mutation screening by REF with low concentrations of urea: A blinded analysis of a 2-kb region of the p53 gene reveals two common haplotypes. Hum Mutat 14:175-80
|
|
Heit, J A; Ketterling, R P; Zapata, R E et al. (1999) Haemophilia B Brandenberg-type promoter mutation. Haemophilia 5:73-5
|
|
Thorland, E C; Drost, J B; Lusher, J M et al. (1999) Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk. Haemophilia 5:101-5
|
Showing the most recent 10 out of 37 publications
